FDA inspection
BENEV Company Inc: FDA inspection ending Mar 16, 2006
FDA inspection 418886 · Voluntary Action Indicated (VAI) · Mission Viejo, CA
Key facts
| Inspection ID | 418886 |
|---|---|
| Firm | BENEV Company Inc |
| FEI number | 3003205477 |
| Address | 23263 Madero Ste A |
| City | Mission Viejo |
| State | CA |
| ZIP | 92691-2767 |
| Fiscal year | 2006 |
| Inspection end date | Mar 16, 2006 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs |
| Product type | Drugs, Food/Cosmetics |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data